Association of Industry Sponsorship With Cancer Clinical Trial Accrual
Overview
Affiliations
Improving drug repositioning with negative data labeling using large language models.
Picard M, Leclercq M, Bodein A, Scott-Boyer M, Perin O, Droit A J Cheminform. 2025; 17(1):16.
PMID: 39905466 PMC: 11796214. DOI: 10.1186/s13321-025-00962-0.
Sherry A, Msaouel P, Kupferman G, Lin T, Abi Jaoude J, Kouzy R medRxiv. 2024; .
PMID: 39108512 PMC: 11302607. DOI: 10.1101/2024.07.23.24310891.
Text Classification of Cancer Clinical Trial Eligibility Criteria.
Yang Y, Jayaraj S, Ludmir E, Roberts K AMIA Annu Symp Proc. 2024; 2023:1304-1313.
PMID: 38222417 PMC: 10785908.
Sherry A, Corrigan K, Kouzy R, Abi Jaoude J, Yang Y, Patel R Cancer. 2023; 129(21):3430-3438.
PMID: 37382235 PMC: 11349322. DOI: 10.1002/cncr.34929.
Prostate cancer clinical trial completion: The role of geography.
Stensland K, Kaffenberger S, George A, Morgan T, Miller D, Salami S Contemp Clin Trials. 2021; 111:106600.
PMID: 34673273 PMC: 8908357. DOI: 10.1016/j.cct.2021.106600.